Piper Jaffray Reiterates Overweight and PT of $57 on St. Jude Medical

Piper Jaffray reiterated its Overweight rating on St. Jude Medical STJ. At the same time, the rating agency left its price target on the company's stock unchanged at $57. On Wednesday, STJ added 2.11% to its value to finish the day at $47.81. However, its shares lost some of yesterday's gains in today's pre-market trading, falling 0.43% to $47.61.